CNA CNA Financial Corporation
XNYS
47.35
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
What changed
Recent filings, trades and moves- 52-Week Range
- $41.53 – $55.71
- YTD
- +1.03%
- IV Rank (30D)
- 21.41
- Straddle Price
- $4.88
- P/C Vol Ratio
- 0.29
- Market Cap
- $12.8B
- Open
- $47.68
- Day Range
- $46.73 – $47.93
- Volume
- 138,022
- Prev Close
- $47.32
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.90% |
| Beta vs SPY | 0.60 |
| Cost of Equity (CAPM) | 7.92% (VRP-adj) |
| WACC | 7.45% |
| Volatility Risk Premium | +31.7pp (IV − HV30) |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | -1.1% |
| DCF Horizon | 10 years explicit + fade |
| Free Cash Flow (TTM) | $2.2B |
| Return on Equity (TTM) | 11.1% |
| Book / Price | 84.3% — banking bias active (P/B is primary) |
| Bank Quality Adj | ×0.90 (target ROE vs peer median) |
| Gross Margin (TTM) | 31.2% |
| FCF Margin (TTM) | 14.9% |
| Debt / Equity | 0.27 |
| Quality Score | 2/6 — normal (10y DCF) |
| SMA 50 | $47.54 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $47.94 |
| Bollinger Width / SMA20 | 5.7% (drives anchor stability) |
| Net Debt | $2.5B |
| Market Cap | $13B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $127.58 | 26% | |
| DDM (Gordon) | $48.17 | 0% | |
| Peer P/E | $46.58 | 8% | median 11.6× · 7 peers |
| Peer EV/EBITDA | n/a | 0% | median 7.5× · 7 peers |
| Peer P/B | $61.40 | 12% | median 1.5× · 7 peers |
| Peer P/S | $62.78 | 4% | median 1.3× · 7 peers |
| Market Anchor (SMA50) | $47.54 | 51% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | $48.98 | 0% | 8 strikes · skew +0.16 |
- Industry (SIC)
- FIRE, MARINE & CASUALTY INSURANCE (6331) · industry map
- Exchange
- XNYS
- Market Cap
- $12.8B
- Employees
- 6,600
- List Date
- 1969-02-03
- CIK
- 0000021175
- Last Earnings
- Nov 2 before open · −1.6% vs ±10.5% expected
- Next Earnings
- ~Feb 8, 2027 (estimated)
- Headquarters
- Chicago, IL
- Homepage
- https://www.cna.com
CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance. The company operates under five segments: Specialty, Commercial and International being its core business, and two segments for its non-core businesses, which are Life and Group and Corporate and Other. CNAF, through its segments, provides professional, financial, specialty property, and casualty products to small businesses and medium-scale organizations. It has its business spread across Continental Europe, United Kingdom, and Canada. The majority of the revenues are gen…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 1.05% | 2.73% | 2.78% | 3.11% | 2.17% | 2.11% | 2.32% |
| Feb | 9.44% | -0.89% | 2.63% | 1.15% | 0.25% | -0.68% | 1.98% |
| Mar | 3.41% | 9.21% | -11.17% | 5.48% | 1.89% | -7.38% | 0.24% |
| Apr | 2.44% | -4.06% | -0.46% | -1.83% | -5.35% | 5.49% | -0.63% |
| May | 0.29% | 2.14% | -5.61% | 3.17% | 0.99% | -12.45% | -1.91% |
| Jun | -5.21% | -1.47% | 4.60% | 1.05% | -3.74% | 16.01% | 1.87% |
| Jul | -4.45% | -5.96% | 0.77% | 7.88% | -4.63% | 5.67% | -0.12% |
| Aug | 1.26% | -6.51% | -0.46% | 5.66% | 12.90% | -9.37% | 0.58% |
| Sep | -5.86% | -4.82% | -0.73% | -5.34% | -5.14% | -7.81% | -4.95% |
| Oct | 5.33% | 10.67% | 3.48% | -2.44% | -3.09% | 6.10% | 3.34% |
| Nov | -9.54% | 0.42% | 3.39% | 6.17% | 6.13% | -1.17%* | 0.90% |
| Dec | 5.48% | 0.17% | 0.21% | -2.91% | 3.38% | -- | 1.27% |
| Total | 1.95% | 0.01% | -1.69% | 22.17% | 4.28% | -6.83% | 3.32% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
Executive Summary
This report provides a comprehensive analysis of CNA (CNA). Overall assessment: NEUTRAL with confidence level 6/10.
Key drivers:
- Technical indicators suggest a bearish trend, with the MACD indicating a bearish momentum.
- RSI is in neutral territory, suggesting no clear buying or selling pressure.
- Bollinger Bands are currently compressed, indicating potential mean reversion.
Primary risks:
- Volatility has increased recently, with IV Premium vs HV30 reaching 120.0%.
- Options market is pricing a $3.80 move by expiration, which could be a catalyst for significant price movement.
Investment thesis: CNA's recent performance is driven by bearish momentum and compressed Bollinger Bands. While the options market suggests potential for volatility-driven moves, the stock's technical indicators are neutral, suggesting no clear direction. Recent news headlines have been mixed, with some indicating positive sentiment (GlobeNewswire Inc.) and others being negative (The Motley Fool).
Recent news sentiment impact: The recent news headlines have had a mixed impact on CNA's price movement. The positive headline from GlobeNewswire Inc. has contributed to the stock's recent bounce, while the negative headlines from The Motley Fool and Benzinga have weighed on the stock.
Technical Analysis
Trend Direction: Short-term: BEARISH (1-4 weeks), Medium-term: NEUTRAL (1-3 months), Long-term: NEUTRAL (3-12 months)
Support/Resistance Levels: Key price levels from moving averages and technical patterns:
- Upper Bollinger Band: $47.05
- Middle Bollinger Band: $44.11
- Lower Bollinger Band: $41.17
Momentum Signals: RSI interpretation: 32.31 (neutral) MACD signal: -0.88 / Signal: -0.05 / Histogram: -0.83 (bearish) Bollinger Bands position: compressed
News & Sentiment Analysis
Recent Headlines Summary: Key themes from last 10 news articles:
- Mixed sentiment, with some headlines indicating positive sentiment and others being negative.
- Recent earnings reports have been mixed, with some companies beating estimates and others missing.
Sentiment Assessment: Aggregate news sentiment: NEUTRAL (4/5 headlines)
Catalyst Identification: Upcoming events, earnings, product launches, regulatory changes:
- Earnings release: not available
- Product launch: not available
- Regulatory changes: not applicable
Risk & Volatility Assessment
Beta Interpretation: Risk relative to market (beta >1.2 = high risk, <0.8 = defensive): 0.17 (low volatility)
Volatility Regime: Current vs historical volatility levels:
- Historical volatility: HV20 33.8%, HV30 29.8%, HV60 23.9%
- Current volatility: 65.6% IV Rank
Options Market Signals: IV rank: 48.5%, current IV: 65.6%
Market Context & Positioning
Sector Performance: Relative strength vs sector/market:
- Sector performance: not available
- Relative to market: not applicable
Institutional Activity: Volume patterns suggesting institutional interest:
- Recent trading volume has been low, with no clear institutional interest signals.
Correlation Analysis: How stock moves relative to market (R-squared interpretation):
- Correlation coefficient: 0.10
Key Levels & Action Items
Critical Price Levels: Support/resistance levels from moving averages and technical patterns:
- Upper Bollinger Band: $47.05
- Middle Bollinger Band: $44.11
- Lower Bollinger Band: $41.17
Breakout/Breakdown Levels: Technical levels that could trigger significant moves:
- No clear breakout/breakdown levels identified.
Time-Sensitive Catalysts: Earnings dates, FDA approvals, product launches:
- Earnings release: not available
- Product launch: not available
- Regulatory changes: not applicable
Risk Management: Stop-loss levels and position sizing considerations:
- Consider setting a stop-loss at $41.17 (lower Bollinger Band) to manage risk.
- Position sizing should be adjusted based on individual risk tolerance and market conditions.
Overall, CNA's technical indicators suggest a bearish trend, with the MACD indicating a bearish momentum. The options market is pricing a potential $3.80 move by expiration, which could be a catalyst for significant price movement. However, recent news headlines have been mixed, and the stock's volatility has increased recently. As such, caution is advised when considering investment in CNA.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-02-08 | Pre-Market | 8.32% | 4.74% | 0.57x | Within |
| 2021-08-02 | Pre-Market | 3.18% | 0.48% | 0.15x | Within |
| 2021-11-01 | Pre-Market | 5.68% | 2.61% | 0.46x | Within |
| 2022-02-07 | Pre-Market | 7.57% | 0.00% | 0.00x | Within |
| 2022-05-02 | Pre-Market | 2.53% | 5.40% | 2.13x | Exceeded |
| 2022-10-31 | Pre-Market | 6.76% | 1.04% | 0.15x | Within |
| 2023-02-06 | Pre-Market | 2.52% | 2.16% | 0.86x | Within |
| 2023-05-01 | Pre-Market | 9.59% | 0.36% | 0.04x | Within |
| 2023-07-31 | Pre-Market | 4.96% | 1.95% | 0.39x | Within |
| 2023-10-30 | Pre-Market | 6.65% | 0.83% | 0.12x | Within |
| 2024-02-05 | Pre-Market | 7.57% | 7.16% | 0.95x | Within |
| 2024-05-06 | Pre-Market | 5.47% | 0.32% | 0.06x | Within |
| 2024-07-29 | Pre-Market | 5.26% | 1.50% | 0.29x | Within |
| 2024-10-21 | Pre-Market | 7.45% | 1.78% | 0.24x | Within |
| 2024-11-04 | Pre-Market | 8.89% | 1.47% | 0.17x | Within |
| 2025-02-10 | Pre-Market | 5.56% | 1.18% | 0.21x | Within |
| 2025-05-05 | Pre-Market | 5.69% | 0.62% | 0.11x | Within |
| 2025-08-04 | Pre-Market | 4.73% | 4.03% | 0.85x | Within |
| 2025-11-03 | Pre-Market | 9.32% | 1.12% | 0.12x | Within |
| 2026-02-09 | Pre-Market | 8.33% | 1.40% | 0.17x | Within |
| 2026-05-04 | Pre-Market | 6.66% | 7.95% | 1.19x | Exceeded |
| 2026-08-03 | Pre-Market | 7.48% | 2.13% | 0.28x | Within |
| 2026-11-02 | Pre-Market | 10.53% | 1.56% | 0.15x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
CNA Options Activity & IV Rank
CNA IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow · All expiries
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Estimated net dealer gamma is at the 65th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Loading the implied volatility surface…
Loading the implied volatility smile…
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Negative beta - stock moves opposite to market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $24.3M | #1013 of 3716 | +1164.2% | 13F | |
| Citadel Hedge fund Ken Griffin | $12.3M | #1437 of 6285 | +76.7% | 13F | |
| Point72 Hedge fund Steve Cohen | $6.9M | #884 of 1945 | +460.9% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $36K | #3504 of 4729 | +14.4% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
CNA Institutional Ownership (13F)
Filings for 2026-06-30 · 147 already for 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Jane Street Group, LLC Custodian | $3.67M | 55.48% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $1.76M | 26.63% | 2026-06-30 |
| 3 | Susquehanna International Group, LLP Custodian | $806.93K | 12.21% | 2026-06-30 |
| 4 | Simplex Trading, LLC Custodian | $341.09K | 5.16% | 2026-09-30 |
| 5 | GROUP ONE TRADING LLC Custodian | $34.03K | 0.52% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Citadel Advisors LLC Custodian | $1.53M | 86.08% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $218.75K | 12.34% | 2026-06-30 |
| 3 | GROUP ONE TRADING LLC Custodian | $14.58K | 0.82% | 2026-06-30 |
| 4 | Simplex Trading, LLC Custodian | $13.46K | 0.76% | 2026-09-30 |
CNA Insider Trading (Form 4)
Latest: 2026-11-04| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-11-04 | Scott R Lindquist | EVP & CFO | Sell (S) | −23,579 | $47.64 | -$1.12M | EDGAR |
| 2026-08-05 | Mark Steven James | EVP, Chief Risk & Rein Off | Sell (S) | −8,273 | $53.15 | -$439.7K | EDGAR |
| 2026-08-04 | Daniel Paul Franzetti | EVP & CAO | Sell (S) | −22,656 | $53.09 | -$1.20M | EDGAR |
| 2026-03-20 | Jeffrey John Neuenschwander | SVP & General Counsel | Sell (S) | −3,287 | $45.97 | -$151.1K | EDGAR |
| 2026-03-17 | Jeffrey John Neuenschwander | SVP & General Counsel | Mixed Tax −1,361 · Grant +3,540 |
+2,179 | $47.03 | -$64.0K | EDGAR |
| 2026-03-17 | Jane Elizabeth Possell | EVP & CIO | Mixed Tax −7,006 · Grant +19,888 |
+12,882 | $47.03 | -$329.5K | EDGAR |
| 2026-03-17 | Robert Joseph Hopper | EVP & Chief Actuary | Mixed Grant +19,888 · Tax −12,758 |
+7,130 | $47.03 | -$600.0K | EDGAR |
| 2026-03-17 | Amy Marie Smith | SVP & Chief Accounting Officer | Mixed Tax −1,787 · Grant +4,773 |
+2,986 | $47.03 | -$84.0K | EDGAR |
| 2026-03-17 | Elizabeth Ann Aguinaga | EVP, Chief HR Officer | Mixed Tax −11,512 · Grant +19,888 |
+8,376 | $47.03 | -$541.4K | EDGAR |
| 2026-03-17 | Daniel Paul Franzetti | EVP & CAO | Mixed Tax −18,018 · Grant +33,094 |
+15,076 | $47.03 | -$847.4K | EDGAR |
| 2026-03-17 | Scott R Lindquist | EVP & CFO | Mixed Grant +37,232 · Tax −18,603 |
+18,629 | $47.03 | -$874.9K | EDGAR |
| 2026-03-17 | Mark Steven James | EVP, Chief Risk & Rein Off | Mixed Grant +14,451 · Tax −6,791 |
+7,660 | $47.03 | -$319.4K | EDGAR |
| 2026-03-17 | Douglas Worman | Chairman and CEO | Mixed Tax −37,062 · Grant +106,075 |
+69,013 | $47.03 | -$1.74M | EDGAR |
| 2026-01-06 | Dino Robusto | Executive Chairman | Sell (S) | −6,250 | $47.62 | -$297.6K | EDGAR |
| 2025-12-01 | Dino Robusto | Executive Chairman | Sell (S) | −6,250 | $46.92 | -$293.2K | EDGAR |
CNA Insider Holdings
11 insiders · @ $47.34| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Dino Robusto | Executive Chairman | 661,838 | $31.33M | -$2.77M | 24 | 2026-01-06 |
| 2 | Douglas Worman | Chairman and CEO | 276,811 | $13.11M | -$4.60M | 18 | 2026-03-17 |
| 3 | Robert Joseph Hopper | EVP & Chief Actuary | 85,808 | $4.06M | $0 | 8 | 2026-03-17 |
| 4 | Elizabeth Ann Aguinaga | EVP, Chief HR Officer | 79,693 | $3.77M | -$1.91M | 12 | 2026-03-17 |
| 5 | Scott R Lindquist | EVP & CFO | 76,537 | $3.62M | -$2.02M | 6 | 2026-11-04 |
| 6 | Daniel Paul Franzetti | EVP & CAO | 68,032 | $3.22M | -$3.76M | 12 | 2026-08-04 |
| 7 | Jane Elizabeth Possell | EVP & CIO | 64,822 | $3.07M | -$213.7K | 5 | 2026-03-17 |
| 8 | Susan Ann Stone | EVP & General Counsel | 44,331 | $2.10M | -$680.1K | 9 | 2025-08-01 |
| 9 | Mark Steven James | EVP, Chief Risk & Rein Off | 26,446 | $1.25M | -$1.62M | 7 | 2026-08-05 |
| 10 | Amy Marie Smith | SVP & Chief Accounting Officer | 26,144 | $1.24M | $0 | 7 | 2026-03-17 |
CNA Board & Officers
As of SEC filings through Nov 4, 2026Directors 6
- Andre Rice · since Apr 26, 2017
- Michael A Bless · since Oct 13, 2017
- Benjamin J Tisch · since Apr 25, 2018
- Jane J. Wang · since Jan 1, 2019
- Kenneth I Siegel · since Apr 24, 2019
- Douglas Worman · listed since Mar 2025
Officers 9
- Scott R Lindquist · EVP & CFO · since Feb 2, 2022
- Elizabeth Ann Aguinaga · EVP, Chief HR Officer · since Feb 7, 2018
- Robert Joseph Hopper · EVP & Chief Actuary · listed since Mar 2021
- Mark Steven James · EVP, Chief Risk & Rein Off · since Jul 27, 2022
- Jeffrey John Neuenschwander · SVP & General Counsel · since Oct 29, 2025
- Douglas Worman · EVP & Head of Underwriting · listed since Mar 2022
- Jane Elizabeth Possell · EVP & CIO · since Jul 26, 2023
- Daniel Paul Franzetti · EVP & CAO · listed since Mar 2024
- Amy Marie Smith · SVP & CAO · since Dec 2, 2021
Changes in the last 10 years (46)
| Jan 6, 2026 | Dino Robusto reported in an SEC filing no longer being a director |
| Jan 6, 2026 | Dino Robusto reported in an SEC filing no longer being Executive Chairman |
| Oct 29, 2025 | Jeffrey John Neuenschwander became SVP & General Counsel |
| Aug 1, 2025 | Susan Ann Stone reported in an SEC filing no longer being EVP & General Counsel |
| Mar 18, 2025 | Douglas Worman first listed as a director in an SEC filing |
| Mar 18, 2025 | Dino Robusto listed as Executive Chairman (previously Chairman & CEO) in SEC filings |
| Mar 19, 2024 | Daniel Paul Franzetti listed as EVP & CAO (previously EVP, Claims) in SEC filings |
| Jul 26, 2023 | Jane Elizabeth Possell became EVP & CIO |
| Jul 27, 2022 | Mark Steven James became EVP, Chief Risk & Rein Off |
| Mar 17, 2022 | Michael Anthony Costonis listed as EVP, Head of Marketing (previously EVP & Chief Operations Officer) in SEC filings |
| Mar 17, 2022 | Douglas Worman listed as EVP & Head of Underwriting (previously EVP & Chief Underwriting Off) in SEC filings |
| Feb 2, 2022 | Scott R Lindquist became EVP & CFO |
| Jan 10, 2022 | The company announced the departure of Kevin James Leidwinger as President & COO, Commerical in an SEC filing |
| Dec 2, 2021 | Amy Marie Smith became SVP & CAO |
| Oct 27, 2021 | Gary Haase became EVP & COO |
| Jul 28, 2021 | Susan Ann Stone became EVP & General Counsel |
| Mar 1, 2021 | Robert Joseph Hopper listed as EVP & Chief Actuary (previously EVP, Actuary) in SEC filings |
| Sep 1, 2020 | Nick Creatura became President & CEO for Canada |
| Sep 1, 2020 | Jalil Rehman became Pres. & CEO for UK and Europe |
| Apr 29, 2020 | Robert Joseph Hopper became EVP, Actuary |
| Apr 29, 2020 | Daniel Paul Franzetti became EVP, Claims |
| Mar 17, 2020 | James Michael Anderson reported in an SEC filing no longer being EVP & Chief Financial Officer |
| Mar 17, 2020 | Albert Joseph Miralles Jr listed as EVP & Chief Financial Officer (previously EVP & Chief Risk Officer) in SEC filings |
| Jul 31, 2019 | Jose Ramon Gonzalez became EVP & General Counsel |
| Apr 24, 2019 | Kenneth I Siegel became a director |
| Feb 1, 2019 | Joseph Gerard Merten reported in an SEC filing no longer being EVP, Technology & Operations |
| Jan 4, 2019 | D Craig Mense reported in an SEC filing no longer being EVP & CFO |
| Jan 1, 2019 | Jane J. Wang became a director |
| Oct 31, 2018 | Michael Anthony Costonis became EVP & Chief Operations Officer |
| Aug 1, 2018 | James Michael Anderson became EVP & Chief Financial Officer |
| Apr 25, 2018 | Benjamin J Tisch became a director |
| Mar 19, 2018 | Albert Joseph Miralles Jr listed as EVP & Chief Risk Officer (previously President, Long-Term Care) in SEC filings |
| Feb 7, 2018 | Elizabeth Ann Aguinaga became EVP, Chief HR Officer |
| Jan 3, 2018 | Timothy J Szerlong reported in an SEC filing no longer being President, Worldwide Field Ops |
| Oct 13, 2017 | Michael A Bless became a director |
| Jul 11, 2017 | Jonathan D Kantor reported in an SEC filing no longer being EVP, Gen. Counsel & Sec. |
| Jun 5, 2017 | Scott L Weber became EVP & General Counsel |
| Jun 5, 2017 | Kevin Gene Smith became President & COO, Specialty |
| Apr 26, 2017 | Joseph Gerard Merten became EVP, Technology & Operations |
| Apr 26, 2017 | Douglas Worman became EVP & Chief Underwriting Off |
| Apr 26, 2017 | Andre Rice became a director |
| Feb 2, 2017 | Thomas Pontarelli reported in an SEC filing no longer being EVP & Chief Admin Officer |
| Jan 5, 2017 | Thomas F Motamed reported in an SEC filing no longer being a director |
| Jan 5, 2017 | Thomas F Motamed reported in an SEC filing no longer being Chairman and CEO |
| Nov 20, 2016 | Dino Robusto became a director |
| Nov 20, 2016 | Dino Robusto became Chairman & CEO |
- Prev
- 1
Not reported recently (15)
- Loews Corp · Last reported as a 10% owner in an SEC filing dated Aug 2, 2023
- Michael Anthony Costonis · Last reported as EVP, Head of Marketing in an SEC filing dated Mar 17, 2023
- Gary Haase · Last reported as EVP & COO in an SEC filing dated Mar 17, 2023
- Kevin Gene Smith · Last reported as President & COO, Specialty in an SEC filing dated Mar 17, 2022
- Larry A. Haefner · Last reported as EVP & Chief Actuary in an SEC filing dated Sep 13, 2021
- Albert Joseph Miralles Jr · Last reported as EVP & Chief Financial Officer in an SEC filing dated Mar 16, 2021
- Jalil Rehman · Last reported as Pres. & CEO for UK and Europe in an SEC filing dated Sep 1, 2020
- Nick Creatura · Last reported as President & CEO for Canada in an SEC filing dated Sep 1, 2020
- Jose Ramon Gonzalez · Last reported as EVP & General Counsel in an SEC filing dated Jul 30, 2020
- David John Brosnan · Last reported as President, International in an SEC filing dated Mar 17, 2020
- Andrew J Pinkes · Last reported as EVP, Worldwide P&C Claim in an SEC filing dated May 1, 2019
- Scott L Weber · Last reported as EVP & General Counsel in an SEC filing dated Mar 19, 2019
- Marvin Zonis · Last reported as a director in an SEC filing dated Feb 14, 2018
- Joseph Rosenberg · Last reported as a director in an SEC filing dated May 3, 2017
- Mark Herman · Last reported as President & COO, CNA Specialty in an SEC filing dated Mar 17, 2017
CNA Proposed Insider Sales (Form 144)
Latest: 2026-11-03What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-11-03 | SCOTT LINDQUIST | Officer | 23,579 | $1.12M | 2026-11-03 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-08-04 | MARK JAMES | Officer | 8,273 | $439.8K | 2026-08-04 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-08-04 | DANIEL FRANZETTI | Officer | 22,656 | $1.20M | 2026-08-04 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-03-19 | JEFFREY NEUENSCHWANDER | Officer | 3,287 | $151.1K | 2026-03-19 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-02-02 | Robusto Dino | Officer | 6,250 | $300.7K | 2026-02-02 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-01-02 | Robusto Dino | Officer | 6,250 | $297.6K | 2026-01-02 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2025-12-01 | Robusto Dino | Officer | 6,250 | $293.2K | 2025-12-01 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2025-11-03 | Robusto Dino | Officer | 6,250 | $283.0K | 2025-11-03 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2025-10-01 | Robusto Dino | Officer | 6,250 | $289.1K | 2025-10-01 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2025-09-04 | Scott R. Lindquist | Officer | 8,380 | $410.2K | 2025-09-04 | Goldman Sachs & Co. LLC | — | EDGAR |
| Filing Date | Event | Link |
|---|---|---|
| 2026-11-02 | Earnings results | EDGAR |
| 2026-08-03 | Earnings results | EDGAR |
| 2026-05-04 | Earnings results | EDGAR |
| 2026-04-29 | Shareholder vote results | EDGAR |
| 2026-02-09 | Earnings results | EDGAR |
| 2025-11-03 | Earnings results | EDGAR |
| 2025-11-03 | Director or officer change | EDGAR |
| 2025-08-12 | Other events | EDGAR |
| 2025-08-11 | Material agreement | EDGAR |
| 2025-08-04 | Earnings results | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-02-10 | 0000021175-26-000011 | EDGAR |
| 2025-02-11 | 0000021175-25-000008 | EDGAR |
| 2024-02-06 | 0000021175-24-000007 | EDGAR |
| 2023-02-07 | 0000021175-23-000006 | EDGAR |
| 2022-02-08 | 0000021175-22-000016 | EDGAR |
| 2021-02-09 | 0000021175-21-000022 | EDGAR |
| 2020-02-11 | 0000021175-20-000017 | EDGAR |
| 2019-02-13 | 0000021175-19-000022 | EDGAR |
| 2018-02-14 | 0000021175-18-000019 | EDGAR |
| 2017-02-15 | 0000021175-17-000040 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-11-02 | 0000021175-26-000058 | EDGAR |
| 2026-08-03 | 0000021175-26-000045 | EDGAR |
| 2026-05-04 | 0000021175-26-000031 | EDGAR |
| 2025-11-03 | 0000021175-25-000097 | EDGAR |
| 2025-08-04 | 0000021175-25-000074 | EDGAR |
| 2025-05-05 | 0000021175-25-000049 | EDGAR |
| 2024-11-04 | 0000021175-24-000095 | EDGAR |
| 2024-07-29 | 0000021175-24-000056 | EDGAR |
| 2024-05-06 | 0000021175-24-000039 | EDGAR |
| 2023-10-30 | 0000021175-23-000065 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VXUS Vanguard Total International Stock ETF | Vanguard | 0.02% | $134.3M | — | 2026-09-30 |
| 2 | VEA Vanguard FTSE Developed Markets ETF | Vanguard | 0.03% | $88.5M | — | 2026-09-30 |
| 3 | IEFA iShares Core MSCI EAFE ETF | iShares (BlackRock) | 0.04% | $68.9M | $187.1B | 2026-11-06 |
| 4 | EFA iShares MSCI EAFE ETF | iShares (BlackRock) | 0.04% | $32.6M | $75.5B | 2026-11-06 |
| 5 | FVD First Trust Value Line® Dividend Index Fund | First Trust | 0.40% | $32.2M | $8.1B | 2026-11-06 |
| 6 | SCHD Schwab U.S. Dividend Equity ETF | Nport | 0.03% | $28.7M | — | 2026-08-31 |
| 7 | VGK Vanguard FTSE Europe ETF | Vanguard | 0.06% | $21.8M | — | 2026-09-30 |
| 8 | VEU Vanguard FTSE All-World Ex-US ETF | Vanguard | 0.02% | $21.6M | — | 2026-09-30 |
| 9 | SPDW State Street® SPDR® Portfolio Developed World ex-US ETF | SPDR (State Street) | 0.04% | $17.0M | $41.0B | 2026-11-05 |
| 10 | EFG iShares MSCI EAFE Growth ETF | iShares (BlackRock) | 0.09% | $13.7M | $14.8B | 2026-11-06 |
| 11 | IXUS iShares Core MSCI Total International Stock ETF | iShares (BlackRock) | 0.02% | $13.7M | $56.4B | 2026-11-06 |
| 12 | FXO First Trust Financials AlphaDEX® Fund | First Trust | 1.26% | $13.5M | $1.1B | 2026-11-06 |
| 13 | EWU iShares MSCI United Kingdom ETF | iShares (BlackRock) | 0.30% | $11.1M | $3.7B | 2026-11-06 |
| 14 | VXF Vanguard Extended Market ETF | Vanguard | 0.01% | $10.7M | — | 2026-09-30 |
| 15 | VYMI Vanguard International High Dividend Yield ETF | Vanguard | 0.05% | $10.7M | — | 2026-09-30 |
| 16 | IDEV iShares Core MSCI International Developed Markets ETF | iShares (BlackRock) | 0.03% | $10.5M | $33.4B | 2026-11-06 |
| 17 | CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF | Nport | 1.28% | $9.2M | — | 2026-06-30 |
| 18 | VT Vanguard Total World Stock ETF | Vanguard | 0.01% | $8.8M | — | 2026-09-30 |
| 19 | INTF iShares International Equity Factor ETF | iShares (BlackRock) | 0.20% | $7.5M | $3.7B | 2026-11-06 |
| 20 | IEUR iShares Core MSCI Europe ETF | iShares (BlackRock) | 0.06% | $5.5M | $9.6B | 2026-11-06 |
| 21 | IPKW Invesco International BuyBack Achievers ETF | Invesco | 0.93% | $5.2M | — | 2026-11-05 |
| 22 | BSCR Invesco BulletShares 2027 Corporate Bond ETF | Invesco | 0.11% | $5.1M | — | 2026-11-05 |
| 23 | CDL VictoryShares US Large Cap High Div Volatility Wtd ETF | Nport | 1.28% | $5.0M | — | 2026-06-30 |
| 24 | FNDA Schwab Fundamental U.S. Small Company ETF | Nport | 0.05% | $4.8M | — | 2026-08-31 |
| 25 | LGLV State Street® SPDR® US Large Cap Low Volatility Index ETF | SPDR (State Street) | 0.39% | $4.7M | $1.2B | 2026-11-05 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q1 '26 | 2026-03-31 | $3.68B | $211.00M | $0.78 | $393.00M |
| Q4 '25 | 2025-12-31 | $3.83B | $302.00M | $1.11 | $570.00M |
| Q3 '25 | 2025-09-30 | $3.82B | $403.00M | $1.48 | $720.00M |
| Q2 '25 | 2025-06-30 | $3.72B | $299.00M | $1.10 | $562.00M |
| Q1 '25 | 2025-03-31 | $3.63B | $274.00M | $1.00 | $638.00M |
| Q4 '24 | 2024-12-31 | $3.69B | $21.00M | $0.08 | $703.00M |
| Q3 '24 | 2024-09-30 | $3.62B | $283.00M | $1.04 | $748.00M |
| Q2 '24 | 2024-06-30 | $3.52B | $317.00M | $1.17 | $616.00M |
| Q1 '24 | 2024-03-31 | $3.44B | $338.00M | $1.24 | $504.00M |
| Q4 '23 | 2023-12-31 | $3.51B | $367.00M | $1.35 | $520.00M |
| Q3 '23 | 2023-09-30 | $3.34B | $258.00M | $0.95 | $828.00M |
| Q2 '23 | 2023-06-30 | $3.30B | $283.00M | $1.04 | $501.00M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
CNA vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| SHEL Shell plc American Depositary Shares (Ea | $280.6B | — | — | +30.3% | 62 |
| PGR Progressive Corporation | $132.0B | 11.6 | +13.9% | +7.4% | 41 |
| DUK Duke Energy Corporation | $99.6B | 19.4 | +6.3% | +9.8% | 15 |
| PRU Prudential Financial, Inc. | $40.9B | 12.7 | +4.1% | +8.3% | 36 |
| AIG American International Group, Inc. | $40.3B | 14.1 | −2.3% | −5.4% | 38 |
| HIG The Hartford Insurance Group, Inc. | $35.8B | 8.2 | +6.1% | −1.5% | 57 |
| EG Everest Group, Ltd. | $15.2B | 10.9 | +1.2% | +23.7% | 26 |
| CNA CNA Financial Corporation | $12.8B | 10.6 | +4.1% | +1.0% | 21 |
| FNF Fidelity National Financial, Inc. | $11.8B | 15.9 | +14.0% | −17.3% | 26 |
| Peer median | $40.6B | 12.7 | +6.1% | +7.9% | 37 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.